Heart Rate Variability as a Predictor of Rebound Pain Following Total Knee Arthroplasty
The Role of Perioperative Heart Rate Variability in Predicting Rebound Pain After Total Knee Arthroplasty: A Prospective Observational Study
1 other identifier
observational
110
1 country
1
Brief Summary
This study aims to investigate whether heart rate variability (HRV), a marker of autonomic nervous system activity, can predict the occurrence of rebound pain after total knee arthroplasty (TKA). Rebound pain is defined as a sudden and intense pain episode (NRS ≥7) that typically arises after the resolution of peripheral nerve blocks used for postoperative analgesia. Patients undergoing elective unilateral TKA under spinal anesthesia with peripheral nerve blocks will be included. HRV will be measured both before and after surgery using a chest-worn heart rate monitor. Pain levels, analgesic consumption, sleep quality, and patient satisfaction will also be recorded. The primary goal is to determine whether perioperative HRV values can serve as a predictive biomarker for rebound pain. Secondary outcomes include the relationship between HRV and pain intensity, opioid use, sleep quality, and length of hospital stay. The findings may contribute to developing individualized pain management strategies for TKA patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 18, 2025
CompletedStudy Start
First participant enrolled
May 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2025
CompletedJanuary 22, 2026
January 1, 2026
7 months
May 7, 2025
January 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Preoperative LF/HF Ratio as a Predictor of Rebound Pain
To determine whether the preoperative low frequency to high frequency (LF/HF) ratio of heart rate variability is associated with the development of rebound pain after peripheral nerve block resolution. Patients will be classified based on the presence or absence of rebound pain (defined as a shift from NRS ≤3 to ≥7), and mean LF/HF ratios will be compared. Predictive capacity will be evaluated using logistic regression and ROC analysis.
Preoperative (before spinal anesthesia) to 48 hours postoperative
Secondary Outcomes (1)
Association Between HRV Parameters and Pain Intensity
0-48 hours postoperative
Eligibility Criteria
Adult patients aged 18 to 70 years scheduled for elective unilateral total knee arthroplasty under spinal anesthesia at a tertiary care hospital. All participants will receive multimodal analgesia including peripheral nerve blocks as part of standard care.
You may qualify if:
- Age between 18 and 70 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for elective, unilateral total knee arthroplasty under spinal anesthesia
- Planned use of multimodal analgesia including peripheral nerve blocks
- Ability to provide written informed consent
- Ability to understand and complete pain diaries and questionnaires
You may not qualify if:
- Known allergy to local anesthetics
- Contraindications to regional anesthesia
- Contraindications to spinal anesthesia
- ASA physical status IV or higher
- Pregnancy or breastfeeding
- Neurological or psychiatric disorders impairing ability to participate or report outcomes
- Use of anticoagulant therapy or presence of coagulation disorders
- Infection at the proposed injection site
- Emergency (non-elective) surgical procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya City Hospital
Konya, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmut Tutar, MD
KONYA CITY HOSPİTAL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Anesthesiology and Reanimation
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 18, 2025
Study Start
May 20, 2025
Primary Completion
December 20, 2025
Study Completion
December 25, 2025
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The individual participant data will not be shared due to institutional policy and patient confidentiality considerations.